FDA inspection
Seres Therapeutics Inc: FDA inspection ending Jul 29, 2025
FDA inspection 1279457 · No Action Indicated (NAI) · Cambridge, MA
Key facts
| Inspection ID | 1279457 |
|---|---|
| Firm | Seres Therapeutics Inc |
| FEI number | 3012828816 |
| Address | 200 Sidney St # 2 |
| City | Cambridge |
| State | MA |
| ZIP | 02139 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Jul 29, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Vaccines and Allergenic Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data